|
|
|
|
|
(1) |
The US Department of Health and Human Services Centers for Disease Control and Prevention and National Institutes of Health, Biosafety in Biomedical and Microbiological Laboratories, 5th Edition. (2007); available at http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm |
|
(2) |
Paul Berg et al., "Potential Biohazards of Recombinant DNA Molecules." Science. (1974) 185: 303. |
(3) |
|
|
(4) |
|
|
(5) |
Maxine Singer and Dieter Soll, Guidelines for DNA Hybrid Molecules. Science (1973) 181: 1114.
|
(6) |
Monica Barinaga, Asilomar Revisited: Lessons for Today? Science (2000) 287: 1584-5.
|
(7) |
Irving S. Johnson, Human Insulin from Recombinant DNA Technology Science (1983) 219: 632-7.
|
(8) |
|
|
(9) |
|
|
(10) |
Roxanne Khamsi. Lab Loses Trio of Plague Mice. Nature News. September 16, 2005.
|
(11) |
|
(12) |
|
(13) |
Mice Infected With Bubonic Plague Missing. Associated Press. September 15, 2005.
|
(14) |
|
|
(15) |
|
(16) |
|
|
(17) |
John Dudley Miller, "NIH Sued by Boston Biolab Foes. The Scientist. May 19, 2006. |
(18) |
|
(19) |
|
(20) |
Scott Shane, Exposure at Germ Lab Reignites a Public Health Debate. TheNew York Times. January 24, 2005. |
(21) |
Andrew Lawler, "Boston University Under Fire for Pathogen Mishap. Science. (2005) 307: 501.
|
|
|
|